BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sahlström P, Hansson M, Steen J, Amara K, Titcombe PJ, Forsström B, Stålesen R, Israelsson L, Piccoli L, Lundberg K, Klareskog L, Mueller DL, Catrina AI, Skriner K, Malmström V, Grönwall C. Different Hierarchies of Anti–Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis. Arthritis Rheumatol 2020;72:1643-57. [DOI: 10.1002/art.41385] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Raposo B, Afonso M, Israelsson L, Wähämaa H, Stålesen R, Wermeling F, Hensvold AH, Grönwall C, Rethi B, Klareskog L, Malmström V. Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development. Ann Rheum Dis 2023:ard-2022-223417. [PMID: 36604150 DOI: 10.1136/ard-2022-223417] [Reference Citation Analysis]
2 Haro I, Sanmartí R, Gómara MJ. Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis. Int J Mol Sci 2022;23. [PMID: 36555449 DOI: 10.3390/ijms232415803] [Reference Citation Analysis]
3 Raposo B, Afonso M, Israelsson L, Wähämaa H, Stålesen R, Wermeling F, Grönwall C, Rethi B, Klareskog L, Malmström V. Divergent and dominant anti-inflammatory effects of patient-derived anti-citrullinated protein antibodies (ACPA) in arthritis development.. [DOI: 10.1101/2022.09.30.510377] [Reference Citation Analysis]
4 Romão VC, Fonseca JE. Disease mechanisms in preclinical rheumatoid arthritis: A narrative review. Front Med 2022;9. [DOI: 10.3389/fmed.2022.689711] [Reference Citation Analysis]
5 Bruschi M, Cavalli A, Moll S, Candiano G, Scapozza L, Patel JJ, Tan JC, Lo KC, Angeletti A, Ghiggeri GM, Prunotto M. Discovery of anti-Formin-like 1 protein (FMNL1) antibodies in membranous nephropathy and other glomerular diseases. Sci Rep 2022;12:13659. [PMID: 35953506 DOI: 10.1038/s41598-022-17696-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Hardt U, Carlberg K, Af Klint E, Sahlström P, Larsson L, van Vollenhoven A, Hernandez Machado S, Israelsson L, Amara K, Chemin K, Korotkova M, Karlsson Hedestam GB, Catrina AI, Teichmann SA, Ståhl PL, Malmström V. Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis. Sci Rep 2022;12:11876. [PMID: 35831338 DOI: 10.1038/s41598-022-15293-5] [Reference Citation Analysis]
7 Gómez-Bañuelos E, Konig MF, Andrade F. Microbial pathways to subvert host immunity generate citrullinated neoantigens targeted in rheumatoid arthritis. Curr Opin Struct Biol 2022;75:102423. [PMID: 35834948 DOI: 10.1016/j.sbi.2022.102423] [Reference Citation Analysis]
8 Scherer HU, van der Woude D, Toes REM. From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis. Nat Rev Rheumatol 2022. [PMID: 35606567 DOI: 10.1038/s41584-022-00786-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Reijm S, Brehler AS, Rantapää-Dahlqvist S, Kawakami A, Maeda T, Kawashiri SY, Tamai M, van der Woude D, Toes REM. Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis. Ann Rheum Dis 2022:annrheumdis-2022-222326. [PMID: 35459696 DOI: 10.1136/annrheumdis-2022-222326] [Reference Citation Analysis]
10 Khatri S, Hansen J, Pedersen NB, Brandt-Clausen IP, Gram-Nielsen S, Mendes AC, Chronakis IS, Keiding UB, Catrina AI, Rethi B, Clausen MH, Kragstrup T, Astakhova K. Cyclic Citrullinated Peptide Aptamer Treatment Attenuates Collagen-Induced Arthritis. Biomacromolecules 2022. [PMID: 35438963 DOI: 10.1021/acs.biomac.2c00144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Cook K, Xue W, Atabani S, Symonds P, Al Omari A, Daniels I, Shah S, Choudhury RH, Weston D, Metheringham R, Brentville V, Durrant L. Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity. Front Immunol 2022;13:873947. [DOI: 10.3389/fimmu.2022.873947] [Reference Citation Analysis]
12 Rodríguez-martínez L, Regueiro C, Amhaz-escanlar S, Pena C, Herbello-hermelo P, Moreda-piñeiro A, Rodriguez-garcia J, Mera-varela A, Pérez-pampín E, González A. Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis. Diagnostics 2022;12:352. [DOI: 10.3390/diagnostics12020352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Padyukov L. Genetics of rheumatoid arthritis. Semin Immunopathol 2022. [PMID: 35088123 DOI: 10.1007/s00281-022-00912-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
14 Sokolova MV, Schett G, Steffen U. Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings. Clin Rev Allergy Immunol 2022;63:138-51. [PMID: 34495490 DOI: 10.1007/s12016-021-08890-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
15 Mueller AL, Payandeh Z, Mohammadkhani N, Mubarak SMH, Zakeri A, Alagheband Bahrami A, Brockmueller A, Shakibaei M. Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells 2021;10:3017. [PMID: 34831240 DOI: 10.3390/cells10113017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
16 Brevet P, Lattard C, Guillou C, Rottenberg P, Fardellone P, Le-Loët X, Lequerré T, Cosette P, Boyer O, Fréret M, Vittecoq O. Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing In Vivo Epitopes of Its γ Chain One of Which Is Not Cross Reactive With Anti-Citrullinated Protein Antibodies. Front Immunol 2021;12:733511. [PMID: 34691039 DOI: 10.3389/fimmu.2021.733511] [Reference Citation Analysis]
17 Grönwall C, Malmström V. New technologies laying a foundation for next generation clinical serology. EBioMedicine 2021;72:103585. [PMID: 34563922 DOI: 10.1016/j.ebiom.2021.103585] [Reference Citation Analysis]
18 Studenic P, Alunno A, Sieghart D, Bang H, Aletaha D, Blüml S, Haslacher H, Smolen JS, Gerli R, Steiner G. Presence of anti-acetylated peptide antibodies (AAPA) in inflammatory arthritis and other rheumatic diseases suggests discriminative diagnostic capacity towards early rheumatoid arthritis. Ther Adv Musculoskelet Dis 2021;13:1759720X211022533. [PMID: 34539818 DOI: 10.1177/1759720X211022533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Catrina A, Krishnamurthy A, Rethi B. Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis. RMD Open 2021;7:e001228. [PMID: 33771834 DOI: 10.1136/rmdopen-2020-001228] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
20 Poulsen TBG, Damgaard D, Jørgensen MM, Senolt L, Blackburn JM, Nielsen CH, Stensballe A. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays. Sci Rep 2021;11:17300. [PMID: 34453079 DOI: 10.1038/s41598-021-96675-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Hardt U, Carlberg K, Klint EA, Sahlström P, Larsson L, van Vollenhoven A, Machado SH, Israelsson L, Amara K, Chemin K, Korotkova M, Karlsson Hedestam GB, Catrina AI, Teichmann SA, Ståhl PL, Malmström V. Integrated Single Cell and Spatial Transcriptomics Reveal Autoreactive Differentiated B Cells in Joints of Early Rheumatoid Arthritis.. [DOI: 10.1101/2021.08.09.21260015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Shchetynsky K, Brynedal B, Ramsköld D, Israelsson L, Hansson M, Mathsson-alm L, Rönnelid J, Viatte S, Holmdahl R, Catrina A, Alfredsson L, Malmström V, Klareskog L, Gomez-cabrero D, Padyukov L, Rheumatoid Arthritis Consortium International (RACI). Identification of loci genetically associated with antibodies to specific sets of citrullinated peptides in rheumatoid arthritis patients.. [DOI: 10.1101/2021.07.15.21259135] [Reference Citation Analysis]
23 Nogueira L, Parra E, Larrieu M, Verrouil E, Cornillet M. Are antibodies to fine specificities of citrullinated peptides/proteins useful for stratification of rheumatoid arthritis patients? Clin Transl Immunology 2021;10:e1288. [PMID: 34257966 DOI: 10.1002/cti2.1288] [Reference Citation Analysis]
24 Hensvold A, Klareskog L. Towards prevention of autoimmune diseases: The example of rheumatoid arthritis. Eur J Immunol 2021;51:1921-33. [PMID: 34110013 DOI: 10.1002/eji.202048952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Alghamdi MF, Redwan EM. Advances in the diagnosis of autoimmune diseases based on citrullinated peptides/proteins. Expert Rev Mol Diagn 2021;21:685-702. [PMID: 34024239 DOI: 10.1080/14737159.2021.1933946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Trejo-Zambrano MI, Gómez-Bañuelos E, Andrade F. Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis. Antioxid Redox Signal 2021. [PMID: 33906423 DOI: 10.1089/ars.2021.0064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Grönwall C, Liljefors L, Bang H, Hensvold AH, Hansson M, Mathsson-Alm L, Israelsson L, Joshua V, Svärd A, Stålesen R, Titcombe PJ, Steen J, Piccoli L, Sherina N, Clavel C, Svenungsson E, Gunnarsson I, Saevarsdottir S, Kastbom A, Serre G, Alfredsson L, Malmström V, Rönnelid J, Catrina AI, Lundberg K, Klareskog L. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis. Front Immunol 2021;12:627986. [PMID: 34093522 DOI: 10.3389/fimmu.2021.627986] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
28 Song J, Schwenzer A, Wong A, Turcinov S, Rims C, Martinez LR, Arribas-Layton D, Gerstner C, Muir VS, Midwood KS, Malmström V, James EA, Buckner JH. Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis. JCI Insight 2021;6:145217. [PMID: 33507879 DOI: 10.1172/jci.insight.145217] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
29 Kronzer VL, Davis JM 3rd. Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis. Curr Rheumatol Rep 2021;23:21. [PMID: 33646410 DOI: 10.1007/s11926-021-00993-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
30 Zhang Y, Yang Y, Hu X, Wang Z, Li L, Chen P. PADs in cancer: Current and future. Biochim Biophys Acta Rev Cancer 2021;1875:188492. [PMID: 33321174 DOI: 10.1016/j.bbcan.2020.188492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Castellanos-Moreira R, Rodriguez-Garcia SC, Cabrera-Villalba S, Gomara MJ, Salvador G, Ruiz-Esquide V, Ramirez J, Inciarte-Mundo J, Morla R, Garcia-Moreno C, Cuervo A, Gómez-Puerta JA, Cañete JD, Haro I, Sanmarti R. Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis. Ther Adv Musculoskelet Dis 2020;12:1759720X20978139. [PMID: 33354232 DOI: 10.1177/1759720X20978139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]